Amarin Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$807.86 | Buy/Sell | $636.99 | 8.62% | 9 | $727.40B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$144.38 | Buy/Sell | $174.55 | 17.74% | 3 | $347.48B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.28 | Buy/Sell | £165.99 | 40.24% | 16 | £186.46B |
| AMGN | Amgen | Outperform |
4
|
$300.19 | Buy/Sell | $303.65 | 7.36% | 8 | $161.03B |
| PFE | Pfizer | Outperform |
2
|
$28.30 | Buy/Sell | $32.87 | 7.67% | 6 | $160.36B |
| SAN | Sanofi | Outperform |
16
|
88.58€ | Buy/Sell | 102.80€ | 23.05% | 9 | 110.74€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$40.49 | Buy/Sell | $58.15 | 33.37% | 10 | $82.08B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$63.94 | Buy/Sell | $87.82 | 25.12% | 14 | $79.66B |
| BAYN | Bayer | Hold |
5
|
27.80€ | Buy/Sell | 45.15€ | 7.91% | 4 | 27.31€B |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | Buy/Sell | $0.65 | 488.24% | 0 | $44.04M |
| CDXI | Cardax | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% | 0 | $0.00M |